Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
AstraZeneca |
---|---|
Information provided by: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT00573742 |
The purpose of this study is to observe treatment with candesartan cilexetil 16mg for 8 weeks, in uncontrolled hypertensive patients, in improvement of achieving of treatment goals and impact on blood pressure level in patients with uncontrolled hypertension treated with candesartan cilexetil.
Condition | Intervention |
---|---|
Primary Hypertension |
Drug: Candesartan Cilexeotil 16mg |
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Non-Interventional Study on Uncontrolled Hypertensive Patients for Evaluating Efficacy of Candesartan Cilexetil as Monotherapy or Add-on Therapy. |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: AstraZeneca Romania Medical Department Clinical Study, Information | +4021 317 60 41 | otilia.radu@astrazeneca.com |
Romania | |
Research Site | Recruiting |
Bucuresti, Romania | |
Research Site | Recruiting |
Bacau, Romania | |
Research Site | Recruiting |
Braila, Romania | |
Research Site | Recruiting |
Brasov, Romania | |
Research Site | Recruiting |
Cluj, Romania | |
Research Site | Recruiting |
Constanta, Romania | |
Research Site | Recruiting |
Craiova, Romania | |
Research Site | Recruiting |
Galati, Romania | |
Research Site | Recruiting |
Timisoara, Romania | |
Research Site | Recruiting |
Iasi, Romania | |
Research Site | Recruiting |
Lugoj, Romania | |
Research Site | Recruiting |
Oradea, Romania | |
Research Site | Recruiting |
Pitesti, Romania | |
Research Site | Recruiting |
Ploiesti, Romania | |
Research Site | Recruiting |
Sibiu, Romania | |
Research Site | Recruiting |
Ghiroda, Romania |
Study Director: | Cristina Pentiuc | AstraZeneca |
Study ID Numbers: | NIS-ATO-HCH-2007/2 |
Study First Received: | December 13, 2007 |
Last Updated: | April 14, 2008 |
ClinicalTrials.gov Identifier: | NCT00573742 |
Health Authority: | Romainia: National Drug Agency |
hypertension |
Candesartan cilexetil Candesartan Vascular Diseases |
Essential hypertension Angiotensin II Hypertension |
Angiotensin II Type 1 Receptor Blockers Molecular Mechanisms of Pharmacological Action Therapeutic Uses Cardiovascular Diseases |
Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |